Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yuka Matsunaga"'
Autor:
Yuka Matsunaga, Masataka Ishimura, Hazumu Nagata, Kiyoshi Uike, Tadamune Kinjo, Masayuki Ochiai, Kenichiro Yamamura, Hidetoshi Takada, Yoshihisa Tanoue, Masaki Hayakawa, Masanori Matsumoto, Toshiro Hara, Shouichi Ohga
Publikováno v:
Pediatrics and Neonatology, Vol 59, Iss 6, Pp 595-599 (2018)
Background: Thrombotic microangiopathies (TMA) are microvascular occlusive disorders characterized by systemic or intrarenal platelet aggregation, thrombocytopenia, and red cell fragmentation. Post-operative TMA mostly occurs in adult patients with c
Externí odkaz:
https://doaj.org/article/6579ff08cac9426d9eb91cca9f23cc96
Publikováno v:
Cancer Medicine, Vol 2, Iss 2, Pp 130-143 (2013)
Abstract Cellular activity of BM‐ca, a novel humanized anti‐CD20 antibody, was quantitatively compared with that of two other anti‐CD20 antibodies used for clinical practice, rituximab and ofatumumab. The results of a complement‐dependent cyt
Externí odkaz:
https://doaj.org/article/221f9ee0689f46bb96bfed07dfaab059
Autor:
Kouji Nagata, Toshiharu Matsuura, Tadamune Kinjo, Yuka Matsunaga, Masayuki Ochiai, Hirosuke Inoue, Tomoaki Taguchi, Toru Sawano, Shouichi Ohga, Junko Fujiyoshi
Publikováno v:
American journal of medical genetics. Part AREFERENCES. 185(11)
Trisomy 18 (T18) is one of the most commonly diagnosed aneuploidies leading to poor survival outcome. However, little is known about the dual risk of T18 and very low birth weight (VLBW, weighing
Autor:
Mitsuko, Miyase, Yuka, Matsunaga
Publikováno v:
熊本大学教育学部紀要. 67:251-258
Autor:
Shouichi Ohga, Koichi Tanaka, Masako Ichiyama, Taeko Hotta, Yui Koga, Takeshi Kusuda, Masayuki Ochiai, Dongchon Kang, Tomohito Takimoto, Toshiro Hara, Hirosuke Inoue, Masataka Ishimura, Yuka Matsunaga
Publikováno v:
Pediatric Research. 79:81-86
The early diagnosis of inherited thrombophilia in children is challenging because of the rarity and hemostatic maturation. We explored protein C (PC), protein S (PS), and antithrombin (AT) deficiencies in 306 thromboembolic patients aged ≤20 y usin
Autor:
Masanori Matsumoto, Kiyoshi Uike, Tadamune Kinjo, Yuka Matsunaga, Kenichiro Yamamura, Shouichi Ohga, Toshiro Hara, Masataka Ishimura, Masaki Hayakawa, Hidetoshi Takada, Yoshihisa Tanoue, Masayuki Ochiai, Hazumu Nagata
Publikováno v:
Pediatrics and Neonatology, Vol 59, Iss 6, Pp 595-599 (2018)
Background: Thrombotic microangiopathies (TMA) are microvascular occlusive disorders characterized by systemic or intrarenal platelet aggregation, thrombocytopenia, and red cell fragmentation. Post-operative TMA mostly occurs in adult patients with c
Autor:
Yuka Matsunaga
Publikováno v:
JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE. 62:779-784
Publikováno v:
Cancer Medicine
Cellular activity of BM-ca, a novel humanized anti-CD20 antibody, was quantitatively compared with that of two other anti-CD20 antibodies used for clinical practice, rituximab and ofatumumab. The results of a complement-dependent cytotoxicity (CDC) a
Autor:
Takehiko Doi, Masayuki Ochiai, Dongchon Kang, Toshiro Hara, Shoichi Ohga, Tadamune Kinjo, Yuka Matsunaga, Naoko Ito
Publikováno v:
Journal of Perinatology. 33:239-241
Inherited or acquired protein C (PC) deficiency leads to thromboembolic events. Plasma PC activity in infancy is physiologically lower than in adults. We describe a case of neonatal asphyxia and acute renal failure associated with isolated PC deficie
Autor:
Hideaki Kobayashi, Shoko Ishida, Ohtsura Niwa, Michio Nishida, Minoru Takata, Norio Uematsu, Roland A. Newman, Yuka Matsunaga, Eduardo A. Padlan
Publikováno v:
International journal of oncology. 38(2)
Rituximab (chimeric anti-CD20 mAb) is currently used in the treatment of B-NHL and B cell malignancies, alone or in combination with chemotherapy. However, subsets of patients do not initially respond and/or develop resistance to additional treatment